Our Strategic Intent
At TransEnterix, we believe in digitizing the interface between the surgeon and patient in laparoscopy to increase control and reduce surgical variability in today’s value-based healthcare environment.
TransEnterix, Inc. – Founded in 2006
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today’s value-based healthcare environment.
The Company is focused on the commercialization of the Senhance® Surgical System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control.
The Company also developed the SPIDER device and the SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform. The Senhance Surgical System is available for sale in the United States, Europe, Japan, and select other countries.